Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. appears in FDA public data with 2 recalls, 0 510(k) clearances, 6 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0758-2026, Class III) was initiated on July 6, 2026.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 6
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0758-2026 | Class III | Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Cata | July 6, 2026 |
| D-0112-2017 | Class II | Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufacture | July 12, 2016 |